NanoVibronix this week announced it appointed Doron Besser as CEO following the retirement of longtime leader Brian Murphy. The move comes shortly after the company’s acquisition of ENvue Medical, where Besser previously served as CEO. Murphy will remain on the board of directors to support leadership continuity. “Brian has been an integral part of NanoVibronix’s […]
nanovibronix
NanoVibronix announces reverse stock split
NanoVibronix (Nasdaq:NAOV) announced today that it intends to effect a reverse stock split of its common stock. The split comes at a ratio of one post-split share for every 11 pre-split shares. Tyler, Texas-based NanoVibronix expects the split to go into effect at 4:05 p.m. on March 13, 2025. It plans for its common stock […]
NanoVibronix completes pilot study of UroShield
NanoVibronix (Nasdaq:NAOV) announced today that it completed the first phase of a randomized controlled trial for its UroShield device. Researchers at the University of Michigan completed the first phase of the trial for UroShield, a portable ultrasonic therapeutic device. UroShield utilizes patented low-intensity surface acoustic wave (SAW) technology. This allows for the creation of low-frequency […]
NanoVibronix’s UroShield receives positive guidance from UK’s NICE
NanoVibronix today received publication of guidance from National Institute for Health and Care Excellence (NICE) in the U.K. for its UroShield device. England’s Department of Health and Social Care’s NICE issued guidance suggesting that UroShield has the potential to provide significant patient and healthcare system benefits to prevent catheter-associated urinary tract infections. Further U.K.-based research […]
NanoVibronix wins reimbursement from CMS for PainShield device
NanoVibronix (NSDQ:NAOV) announced today that it won a unique reimbursement code from the Centers for Medicare and Medicaid for its PainShield surface acoustic wave portable ultrasonic therapeutic device. The Elmsford, N.Y.–based company develops medical devices based around its low-intensity SAW technology that allows the creation of low-frequency ultrasound waves that can be used in multiple medical […]
NanoVibronix touts trigeminal neuralgia PainShield study data
NanoVibronix (NSDQ:NAOV) yesterday released results from a study exploring the use of its PainShield device in treating patients with trigeminal neuralgia, touting improved pain relief and quality of life. The PainShield is a device designed to treat pain in nerves, muscles and joints through the delivery of localized ultrasound, the Elmsford, N.Y.-based company said. In the […]
7 medtech stories we missed this week: April 6, 2018
From CHF Solutions’s distribution deal to Guided Therapeutics’s licensing agreement, here are seven medtech stories we missed this week but throught were still worth mentioning. 1. CHF inks Spanish distribution deal CHF Solutions announced in an April 5 press release that it has signed a distribution agreement with Dimedix Surgical. The distribution agreement will allow […]
5 medtech stories we missed this week: Dec. 29, 2017
From NanoVibronix’s new Indian regulatory and distribution agreement to Guided Therapeutics’s Turkish distribution deal, here are five medtech stories we missed this week but thought were still worth mentioning. 1. NanoVibronix inks deal with Indian regulatory and distribution consultant NanoVibronix announced in a Dec. 20 press release that it has signed Morulaa HealthTech as its regulatory […]
5 medtech stories we missed this week: Dec. 22, 2017
From Hepa Wash’s new collaboration to Stimwave’s FDA clearance, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Hepa Wash collaborates with GALS program Hepa Wash announced in a Dec. 7 press release that it has collaborated with the German Accelerator Life Sciences (GALS) program to expand its […]
NanoVibronix inks UK UroShield distro deal with IMS Ultrasound
NanoVibronix (NSDQ:NAOV) said today it inked a deal with the U.K.’s IMS Ultrasound to make it the exclusive U.K. distributor of its UroShield device, designed to prevent catheter-acquired urinary tract infections. The UroShield device from the Elmsford, N.Y.-based company is designed to decrease pain and discomfort associated with urinary catheter use while also preventing bacterial colonization […]
NanoVibronix touts lowered UTIs in interim UroShield study results
NanoVibronix (NSDQ:NAOV) today released interim results from a trial of its UroShield ultrasound device designed to prevent bacteria and biofilms from forming on urinary catheters, touting a low rate of catheter-acquired urinary tract infections. The Uroshield device from the Elmsford, N.Y.-based company is designed to decrease pain and discomfort associated with urinary catheter use while also […]
